Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer

BACKGROUND: Prostate cancer (PCa) is the most common malignancy among men in the United States. Though highly sensitive, the often-used prostate-specific antigen (PSA) test has low specificity which leads to overdiagnosis and overtreatment of PCa. This paper presents results of a retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ji, Veltri, Robert W., Yuan, Zhen, Christudass, Christhunesa S., Mandecki, Wlodek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390224/
https://www.ncbi.nlm.nih.gov/pubmed/25853582
http://dx.doi.org/10.1371/journal.pone.0122249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390224/
https://www.ncbi.nlm.nih.gov/pubmed/25853582
http://dx.doi.org/10.1371/journal.pone.0122249

Ejemplares similares